innOWL

PharmaceuticalsSeedSeoul, South Korea

Latest round

Seed

Last raised

Feb 2026

Total raised

Undisclosed

Investors

2

About innOWL

Based in Seoul, South Korea, founded in 2025, innOWL operates as a company that develops a precision diagnostic system for atopic dermatitis that uses a minimally invasive microneedle patch, RNA transcriptome analysis, and artificial intelligence–based subtype classification. The company is developing a precision diagnosis system for atopic dermatitis. Its technology combines microneedle patches, RNA analytics, and AI based modeling to support data driven diagnostic processes. The approach is designed to be minimally invasive while enabling detailed biological analysis. Clinical validation is a key component of product development, with trials currently underway to assess performance and applicability in medical settings.

Who invested in innOWL

2 investors across 1 round

See all investors in innOWL

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Feb 4, 2026

    Amount

    Undisclosed

    Investors

    Locked

Questions about innOWL

Who invested in innOWL?

innOWL has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has innOWL raised?

innOWL has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did innOWL last raise money?

innOWL's most recent round on record is a Seed, in Feb 2026.

What does innOWL do?

Based in Seoul, South Korea, founded in 2025, innOWL operates as a company that develops a precision diagnostic system for atopic dermatitis that uses a minimally invasive microneedle patch, RNA transcriptome analysis, and artificial intelligence–based subtype classification.

Where is innOWL headquartered?

innOWL is headquartered in Seoul, South Korea.

Which VCs invest in companies like innOWL?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at innOWL's stage. Their profiles are linked below.

Raising like innOWL? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.